Phenylketonuria (PKU) is caused by a mutation in the gene responsible for producing the enzyme phenylalanine hydroxylase. This enzyme is crucial for breaking down the amino acid phenylalanine. When this enzyme is defective, phenylalanine keeps building up in the body, leading to toxic effects on the brain and nervous system. Although it is a rare but serious human genetic disorder. If it is left untreated, it can cause intellectual disabilities, developmental delays, and behavioral problems.
In genetics, PKU is an autosomal recessive disorder. It means that an individual must have two defective copies of the gene to express the condition. It is important to study PKU as it helps researchers understand gene interaction. It also has a role in genetic screening and managing disorders. It not only deepens our knowledge about metabolic pathways and the importance of early diagnosis and medical care.
Phenylketonuria is a genetic disorder of protein metabolism in which the body cannot metabolise phenylalanine. This condition is caused by a mutation in the PAH gene, which codes for the production of the enzyme phenylalanine hydroxylase. This enzyme is important for converting phenylalanine into tyrosine, which is important for brain development and metabolism.
PKU is a Mendelian disorder that shows an autosomal recessive pattern. The individual has to inherit two defective copies of the PAH gene, one from either parent, to express the disorder. Individuals who carry only one defective gene are known as carriers. They usually do not show any symptoms but can pass the gene to offspring.
The pathophysiology of PKU involves a block in the normal conversion of phenylalanine to tyrosine due to the lack of dysfunction of phenylalanine hydroxylase. As a result, phenylalanine builds up in the blood and brain. These toxic levels can damage the brain and lead to intellectual disability, impairment in normal cognitive development, and neurological problems.
The high levels of phenylalanine are neurotoxic; early diagnosis and management are critical. It can be done primarily through a special low-phenylalanine diet. Early treatment can prevent serious health issues and help in normal cognitive development.
The symptoms of PKU can vary in severity, but early detection is crucial to prevent long -term damage. Since, the buildup of phenylalanine can impact brain function, physical development and overall human nervous system, timely diagnosis is very essential.
The symptoms usually start to appear in the first few months of life, especially if the condition is left untreated.
Early symptoms include developmental delays and a decrease in intellectual function.
Behavioral problems such as hyperactivity, social withdrawal, and mood swings are also observed.
Physical symptoms may include eczema, a musty odour of the skin and urine from the excess phenylalanine, and lighter skin and hair than unaffected siblings due to reduced melanin production.
PKU diagnosis starts with a newborn screening. A blood sample is collected to check the levels of phenylalanine. If the levels are high, further blood tests are done to accurately measure phenylalanine and tyrosine.Genetic testing can identify specific mutations in the PAH gene. This confirms the diagnosis and supports genetic counseling. Early detection ensures that treatment is started before any significant neurological injury has developed.
Managing PKU primarily involves strict dietary control. This is a very strict diet that restricts amino acid, phenylalanine to very low levels. Since phenylalanine is found in some high-protein foods like meat, fish, eggs, dairy products, nuts, and beans, it must be avoided. In the majority of cases, low-phenylalanine medical foods and amino-acid-based supplements are required to provide phenylalanine levels that are nutritionally adequate without exceeding safe phenylalanine levels. Dietitians modify and individualise the diet according to each condition and track the nutrition of people afflicted with these conditions.
In some cases, medical therapy for PKU includes the use of sapropterin dihydrochloride (BH4). It is a man-made type of cofactor that can increase the activity of phenylalanine hydroxylase in some patients. It allows more flexible diet restrictions. Enzyme substitution therapy is an option to degrade phenylalanine in the blood. Together, these medical treatments and controlled nutrition, provide a tool to control PKU and improve the quality of life among those suffering.
Regular monitoring through blood tests is essential. It can monitor phenylalanine levels to educate the patient whether their dietary and medicinal treatments are working or need some adjustments. Lifelong management is important in order to control phenylalanine levels throughout life to prevent neurologic and cognitive complications.
Phenylketonuria is a serious genetic disorder that can give rise to acute brain damage and neurologic impairment, if untreated. Early diagnosis through newborn screening is crucial to ensure timely treatment and better quality of life. Management through dietary restrictions and medication. Raising awareness and education may increase its detection in the early stage and thus provide treatment.
PKU is also an example of pleiotropy, where a single gene mutation leads to multiple effects on different systems of the body. The ongoing research on PKU brings new therapies that may improve outcomes. A better understanding of metabolic and genetic disorders in general.
Q1. An individual affected by phenylketonuria lacks an enzyme that converts the amino acid __________ into _________.
Tyrosine, phenylalanine
Phenylalanine, tyrosine
Homogentisic acid , phenylalanine
Homogentisic acid , tyrosine
Correct answer: 2) phenylalanine, tyrosine
Explanation:
Phenylketonuria - This is an inborn error of metabolism, also inherited as an autosomal recessive trait.
Causes of Phenylketonuria - The affected individual takes amino acid phenylalanine into tyrosine as a result of phenylalanine and converted into phenylpyruvic acid.
Accumulation of these in the brain results in internal retardation.
Hence, the correct answer is option 2) phenylalanine, tyrosine.
Q2. Choose the statement which is not correct:
An example of pleiotropy is phenylketonuria.
Gene pleiotropy occurs when a gene catalyzes multiple reactions.
Phenylketonuria is caused by a defect in a single gene on chromosome 9.
Phenylketonuria causes phenylalanine to increase in amount in the body.
Correct answer: 3) Phenylketonuria is caused by a defect in a single gene on chromosome 9
Explanation:
Explanation of incorrect statement:
Option B) is incorrect because phenylketonuria is caused by a defect in a single gene on chromosome 12 that codes for enzyme phenylalanine hydroxylase, that affects multiple systems, such as the nervous and integumentary system.
Explanation of correct statements :
Option A) is correct because phenylketonuria is an example of pleiotropy which is an inherited disorder that affects the level of phenylalanine, an amino acid that can be obtained from food, in the human body.
Option C) is correct because Gene pleiotropy occurs when a gene product interacts with multiple other proteins or catalyzes multiple reactions.
Option D) is correct because Phenylketonuria causes phenylalanine to increase in amount in the body which can be very dangerous.
Hence, the correct answer is option 3) Phenylketonuria is caused by a defect in a single gene on chromosome 9.
Also Read:
Typical symptoms of PKU include intellectual disability, behavioural problems, eczema, and a musty smell to the skin and urine caused by high phenylalanine in the blood.
A simple blood test is used to screen for PKU in newborns. The test is mainly done a few days after birth.
People with PKU should not consume high-protein foods in the form of meat, fish, eggs, dairy products, nuts, and some varieties of beans, as these contain high levels of phenylalanine.
There currently is no cure for PKU. It has been nevertheless successfully treated and managed through diet regulation and medical treatments controlling the levels of phenylalanine.
PKU makes daily living hard by requiring a severely limited diet, regular blood tests, and continual medical supervision to prevent neurological damage and maintain health.
Early detection allows for immediate treatment, preventing the buildup of phenylalanine to harmful levels. This is critical for preventing irreversible brain damage and other serious complications associated with untreated PKU.
13 Aug'25 01:17 PM
22 Jul'25 10:33 AM
22 Jul'25 09:43 AM
22 Jul'25 09:40 AM
21 Jul'25 03:55 PM
21 Jul'25 03:49 PM
21 Jul'25 02:31 PM
21 Jul'25 02:10 PM